US patent reforms could see a rise of trade secrets in biotech?
This item talks about how recent court rulings, reform at the USPTO, and how WHO/WTO activities could be weakening the patent system thus leading to more innovation being locked into trade secrets.  This view can be backed up by looking at the filing statistics at USPTO – given the continued innovation in biotech industry the question asked in the article by Michael Gollin (partner at Venable LLP) is “where is innovation going if not into patents?”  The article raises a great deal of interesting points as to what the consequences might be of this trend.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s